Premium
Bosutinib, a L yn/ B tk inhibiting tyrosine kinase inhibitor, is ineffective in advanced systemic mastocytosis
Author(s) -
Randall Nicole,
Courville Elizabeth L.,
Baughn Linda,
Afrin Lawrence,
Ustun Celalettin
Publication year - 2015
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.23942
Subject(s) - systemic mastocytosis , medicine , bosutinib , tryptase , cancer research , gastroenterology , bone marrow , dasatinib , immunology , imatinib , mast cell , myeloid leukemia